Back
Rhythm Pharmaceuticals Vs. Merus NV Industry Stock Comparison
Buy
93
RYTM
Rhythm Pharmaceuticals
Last Price:
42.73
Seasonality Move:
98.16%
Buy
74
MRUS
Merus NV
Last Price:
56.50
Seasonality Move:
6.15%
Buy
93
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $42.77. The Score for RYTM is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
74
Merus NV (MRUS)
is a Buy
Is Merus NV a Buy, Sell or Hold?
- The current Merus NV [MRUS] share price is $56.55. The Score for MRUS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MRUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $42.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
MRUS Stock Price Chart
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 60.37 | Buy |
| Chaikin Money Flow: | -553986 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.9 - 41.18) | Buy |
| Bollinger Bands (100): | (38.15 - 45.47) | Buy |
MRUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.72 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | -65155 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.2 - 56.18) | Buy |
| Bollinger Bands (100): | (39.85 - 50.89) | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.27 | Buy |
| 20-day SMA: | 38.87 | Buy |
| 50-day SMA: | 39.6 | Buy |
| 200-day SMA: | 36.72 | Buy |
| 8-day EMA: | 41.4 | Buy |
| 20-day EMA: | 39.99 | Buy |
| 50-day EMA: | 39.9 | Buy |
| 200-day EMA: | 36.63 | Buy |
MRUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.05 | Buy |
| 20-day SMA: | 52.09 | Buy |
| 50-day SMA: | 47.26 | Buy |
| 200-day SMA: | 35.05 | Buy |
| 8-day EMA: | 55.4 | Buy |
| 20-day EMA: | 52.74 | Buy |
| 50-day EMA: | 48.89 | Buy |
| 200-day EMA: | 38.23 | Buy |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.28 per share, a decrease this year of $1.36 per share, and an increase next year of $2.03 per share.
Merus NV Earnings Growth & MRUS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.33 per share.
Rhythm Pharmaceuticals Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merus NV Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||